Search Results - "KERI, G"

Refine Results
  1. 1

    Systematic review and quality ranking of studies of two phthalate metabolites and anogenital distance, bone health, inflammation, and oxidative stress by Sweeney, Marina R., O'Leary, Keri G., Jeney, Zsuzsanna, Braunlin, Megan C., Gibb, Herman J.

    Published in Critical reviews in toxicology (21-04-2019)
    “…Phthalates are ubiquitous chemical compounds, and two-di-ethyl phthalate (DEP) and di-isobutyl phthalate (DiBP)-are not currently regulated by the U.S…”
    Get full text
    Journal Article
  2. 2

    Debunking the Myth That Technology Is a Barrier for Volunteer Training Delivery by Dorn, Sheri, Hobbs, Keri G

    Published in Journal of extension (01-02-2020)
    “…Georgia 4-H and Extension master gardener (EMG) volunteers were surveyed following required online trainings. Most respondents had access to high-speed…”
    Get more information
    Journal Article
  3. 3

    Effect of pulsed electromagnetic fields on endoplasmic reticulum stress by Keczan, E, Keri, G, Banhegyi, G, Stiller, I

    “…The maintenance of protein homeostasis in the endoplasmic reticulum (ER) is crucial in cell life. Disruption of proteostasis results in ER stress that…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Pharmacophore and binding analysis of known and novel B-RAF kinase inhibitors by Baska, F, Szabadkai, I, Sipos, A, Breza, N, Szántai-Kis, C, Kékesi, L, Garamvölgyi, R, Nemes, Z, Neumann, L, Torka, R, Ullrich, A, Kéri, G, Orfi, L

    Published in Current medicinal chemistry (01-06-2014)
    “…The extensively investigated serine/threonine kinase, B-RAF, is a member of the RAS/RAF/MEK/ERK pathway. It plays important role in the regulation of cell…”
    Get more information
    Journal Article
  6. 6

    Aldrin and Dieldrin: A Reevaluation of the Cancer and Noncancer Dose-Response Assessments by Hooker, Eric P., Fulcher, Keri G., Gibb, Herman J.

    Published in Risk analysis (01-05-2014)
    “…The dose‐response analyses of cancer and noncancer health effects of aldrin and dieldrin were evaluated using current methodology, including benchmark dose…”
    Get full text
    Journal Article
  7. 7

    Comparative characterization of experimental and calculated lipophilicity and anti-tumour activity of isochromanone derivatives by Huszár, M, Varga, A, Horváth, A, Loránd, T, Agócs, A, Idei, M, Mandl, J, Vántus, T, Kéri, G

    Published in Current medicinal chemistry (01-02-2010)
    “…Compound lipophilicity connected to ADME(T)(a) has great importance in drug development and it has to be evaluated by the generally used drug developmental…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Prediction oriented QSAR modelling of EGFR inhibition by Szántai-Kis, C, Kövesdi, I, Eros, D, Bánhegyi, P, Ullrich, A, Kéri, G, Orfi, L

    Published in Current medicinal chemistry (01-02-2006)
    “…Epidermal Growth Factor Receptor (EGFR) is a high priority target in anticancer drug research. Thousands of very effective EGFR inhibitors have been developed…”
    Get more information
    Journal Article
  10. 10

    Continuous Administration of the Somatostatin Structural Derivative /TT-232/ by Subcutaneously Implanted Osmotic Pump Improves the Efficacy and Potency of Antitumor Therapy in Different Mouse and Human Tumor Models by TEJEDA, M, GAAL, D, HULLAN, L, CSUKA, O, SCHWAB, R, SZOKOLOCZI, O, KERI, G. Y

    Published in Anticancer research (01-09-2008)
    “…Background: The somatostatin structural derivative, TT-232, has a special 5-residue ring structure (D-Phe- Cys-Tyr-D-Trp-Lys-Cys -Thr-NH 2 ) and very different…”
    Get full text
    Journal Article
  11. 11

    Covering and radius-covering arrays: Constructions and classification by Colbourn, C.J., Kéri, G., Rivas Soriano, P.P., Schlage-Puchta, J.-C.

    Published in Discrete Applied Mathematics (06-06-2010)
    “…The minimum number of rows in covering arrays (equivalently, surjective codes) and radius-covering arrays (equivalently, surjective codes with a radius) has…”
    Get full text
    Journal Article
  12. 12

    Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties by Hegedűs, C, Özvegy‐Laczka, C, Apáti, Á, Magócsi, M, Német, K, Őrfi, L, Kéri, G, Katona, M, Takáts, Z, Váradi, A, Szakács, G, Sarkadi, B

    Published in British journal of pharmacology (01-10-2009)
    “…Background and purpose:  ABC multidrug transporters (MDR‐ABC proteins) cause multiple drug resistance in cancer and may be involved in the decreased…”
    Get full text
    Journal Article
  13. 13

    Anti‐inflammatory effect of synthetic somatostatin analogues in the rat by Helyes, Zsuzsanna, Pintér, Erika, Németh, József, Kéri, György, Thán, Márta, Oroszi, Gábor, Horváth, Anikó, Szolcsányi, János

    Published in British journal of pharmacology (01-12-2001)
    “…Somatostatin (6.11 nmol kg−1 i.p.) inhibited neurogenic plasma extravasation evoked by 1% mustard oil and non‐neurogenic oedema induced by 5% dextran in the…”
    Get full text
    Journal Article
  14. 14

    Sugar Amino Acid Containing Somatostatin Analogues that Induce Apoptosis in Both Drug-Sensitive and Multidrug-Resistant Tumor Cells by Gruner, Sibylle A. W, Kéri, Gyorgy, Schwab, Richard, Venetianer, Aniko, Kessler, Horst

    Published in Organic letters (15-11-2001)
    “…Resistance to chemotherapy has become a major problem in cancer therapy. The new sugar amino acid (SAA) containing somatostatin analogues presented possess…”
    Get full text
    Journal Article
  15. 15

    Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma by SZENDE, B, HORVATH, A, BÖKÖNYI, G, KERI, G

    Published in British journal of cancer (13-01-2003)
    “…A novel somatostatin analogue, TT-232 (which inhibits the proliferation of various cell cultures and transplantable mouse tumours), was examined regarding its…”
    Get full text
    Journal Article
  16. 16

    Antitumor Activity of the Somatostatin Structural Derivative (TT-232), Against Mouse and Human Melanoma Tumor Models by TEJEDA, M, GAAL, D, HULLAN, L, SCHWAB, R, SZOKOLOCZI, O, KERI, G. Y

    Published in Anticancer research (01-11-2007)
    “…Background: The somatostatin structural deivative, TT-232, has a special 5′-residue ring structure (D-Phe- Cys-Tyr-D-Trp-Lys-Cys -Thr-NH 2 ) and very…”
    Get full text
    Journal Article
  17. 17

    Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat by Helyes, Zsuzsanna, Thán, Márta, Oroszi, Gábor, Pintér, Erika, Németh, József, Kéri, György, Szolcsányi, János

    Published in Neuroscience letters (14-01-2000)
    “…In rats anaesthetized with urethan and pretreated with pipecuronium bromide nocifensive reaction of blood pressure elevation evoked by intraarterial capsaicin…”
    Get full text
    Journal Article
  18. 18

    Novel, selective CDK9 inhibitors for the treatment of HIV infection by Németh, G, Varga, Z, Greff, Z, Bencze, G, Sipos, A, Szántai-Kis, C, Baska, F, Gyuris, A, Kelemenics, K, Szathmáry, Z, Minárovits, J, Kéri, G, Orfi, L

    Published in Current medicinal chemistry (2011)
    “…Cyclin Dependent Kinases (CDKs) are important regulators of cell cycle and gene expression. Since an up-to-date review about the pharmacological inhibitors of…”
    Get more information
    Journal Article
  19. 19

    Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites by SZENDE, B, BÖKÖNYI, Gy, BOCSI, J, KERI, Gy, TIMAR, F, MAGYAR, K

    Published in Journal of Neural Transmission (01-01-2001)
    “…The mode of cytoprotective action of the monoamine oxydase B inhibitor (-)-deprenyl was studied using A-2058 human melanoma cells in culture. Serum deprivation…”
    Get full text
    Journal Article
  20. 20

    A Tumor-Selective Somatostatin Analog (TT-232) with Strong in vitro and in vivo Antitumor Activity by Gy. Keri, Erchegyi, J., Horvath, A., Mezo, I., Idei, M., Vantus, T., Balogh, A., Zs. Vadasz, Gy. Bokonyi, Seprodi, J., Teplan, I., Csuka, O., Tejeda, M., Gaal, D., Zs. Szegedi, Szende, B., Roze, C., Kalthoff, H., Ullrich, A.

    “…We report a series of new in vitro and in vivo data proving the selective antitumor activity of our somatostatin structural derivative, TT-232. In vitro, it…”
    Get full text
    Journal Article